Clinical documentation required for medical policy prior authorizations

Jun. 2026Important Notices

As you know, UPMC Health Plan requires certain clinical documentation/notes in support of a request for prior authorization for the listed procedures below in accordance with its established policies and procedures, in addition to CMS requirements that medical record documentation must support the medical necessity of the services requested.

Beginning on June 26, 2026, our system will be updated to confirm the submission of such information before an authorization will be provided for the following UPMC Health Plan policies.

  • MP PA 142 – Radiation therapy, external beam (EBRT)
  • MP.PA.143 – Radiation Therapy – SRS and SBRT
  • MP PA 146 – Laparoscopic cholecystectomy
  • MP.PA.144 – Sleep Medicine – Sleep Study
  • MP.PA.135 – Lumbar Spinal decompression
  • MP.PA. 137 – Cardiac Devices, Implantable Defibrillator and Pacemaker

As such, please be sure to submit all supporting clinical documentation at the time of your request in accordance with the applicable medical prior authorization policy to avoid delays or denials when reviewing your request.

To submit an authorization, please log in to the secure Provider OnLine website and select Auth Entry/Inquiry from the left-hand navigation to submit the authorization. Clinical documentation will need to be uploaded during the online submission process.

If you have any questions about this update, please contact your provider network liaison. You can also call Provider Services at 1-866-918-1595.


Recent Announcements

CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care

Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.
Sep. 2026Education/Webinars

Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)

Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).
Sep. 2026Pharmacy Updates

Voluntary nationwide recall: Dextrose (Baxter – August 2026)

Baxter International Inc. is recalling one lot (lot Y495066) of 70% Dextrose Injection. Dextrose is used to replenish calories and fluid in certain situations.
Sep. 2026Pharmacy Updates